Immuron Limited Dividend 2022

Immuron Limited (IMC) is an oral immunotherapy research and development and product sales focused on bovine-colostrum enriched with antibodies of choice for the treatment and prevention of a range of infectious and immune modulated diseases. Product sales comprise Travelan and Protectyn, used for the prevention of travellers’ diarrhoea. The group is involved in Research & Development and Hyperimmune Products (occur predominantly in Australia, the Unites States and Canada).

Immuron Limited operators in Health Care sector and under industry of Biotechnology. The company website is:

You can also check out dividend history for similar stocks in the same sector as follows:

IMC Dividend Dates

Please click the table header to sort the data.

No Dividend Dates Found